ImmunityBio (IBRX) Amortization of Deferred Charges (2019 - 2024)
ImmunityBio (IBRX) reported Amortization of Deferred Charges of $5.0 million for Q4 2024, down 29.66% year-over-year from $7.1 million in Q1 2024, and down 19.23% quarter-over-quarter from $6.2 million in Q3 2024.
ImmunityBio (IBRX) Amortization of Deferred Charges (2019 - 2024) Analysis & Trends
ImmunityBio (IBRX) has 4 years of Amortization of Deferred Charges data on file, last reported at $5.0 million in Q4 2024.
- Amortization of Deferred Charges for Q4 2024 came in at $5.0 million, down 29.66% year-over-year; the trailing twelve-month figure through Sep 2025 was $5.0 million (down 79.73% YoY), and the FY2024 annual result was $22.6 million, down 46.72% from the prior year.
- Amortization of Deferred Charges eased to $5.0 million in Q4 2024 per IBRX's latest filing, from $6.2 million in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $12.3 million in Q2 2023 and troughed at -$936000.0 in Q3 2022.
- A 3-year average of $6.8 million and a median of $6.0 million in 2024 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges soared 3017.84% in 2023, then sank 52.54% in 2024.
- A 3-year view of Amortization of Deferred Charges shows it stood at $11.0 million in 2022, then tumbled by 35.53% to $7.1 million in 2023, then declined by 29.66% to $5.0 million in 2024.
- Business Quant data shows IBRX's Amortization of Deferred Charges at $5.0 million in Q4 2024, $6.2 million in Q3 2024, and $5.8 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.01 Mn |
| Dec 31, 2024 | 5.01 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 5.83 Mn |
| Jun 30, 2024 | 5.83 Mn |
| Mar 31, 2024 | 5.55 Mn |
| Mar 31, 2024 | 5.55 Mn |
| Dec 31, 2023 | 7.12 Mn |
| Dec 31, 2023 | 7.12 Mn |
| Sep 30, 2023 | 11.45 Mn |
| Sep 30, 2023 | 11.45 Mn |
| Jun 30, 2023 | 12.29 Mn |
| Jun 30, 2023 | 12.29 Mn |
| Mar 31, 2023 | 11.54 Mn |
| Mar 31, 2023 | 11.54 Mn |
| Dec 31, 2022 | 11.04 Mn |
| Dec 31, 2022 | 11.04 Mn |
| Sep 30, 2022 | -936,000.00 |
| Sep 30, 2022 | -936,000.00 |